Clinical Evaluation of the Next Generation Phaco System

NACompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

September 28, 2020

Primary Completion Date

May 1, 2021

Study Completion Date

May 1, 2021

Conditions
Cataract
Interventions
DEVICE

VERITAS Vision System

The investigators or designees will perform routine small-incision cataract surgery via phacoemulsification and use the VERITAS Vision system. The Investigator or designee will then complete a questionnaire regarding the clinical use of the VERITAS Vision system. The system log files automatically generated by the VERITAS Vision system after completion of each surgery will be collected.

Trial Locations (2)

93301

ACE Eyecare, Inc, Bakersfield

Unknown

Grupo Oftalmo & Plastico, Centro de Oftalmologia y Cirugia Plastica, El Escalón

All Listed Sponsors
lead

Johnson & Johnson Surgical Vision, Inc.

INDUSTRY

NCT04332640 - Clinical Evaluation of the Next Generation Phaco System | Biotech Hunter | Biotech Hunter